Ritam Harin Patel

Mr. Ritam Harin Patel

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2026 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
CWCatherine Y. Wang
Catherine Y. Wang
LMLogan McLennan
Logan McLennan
RPRitam Harin Patel
Ritam Harin Patel
SYSwati Yarlagadda
Swati Yarlagadda
MSMaxwell E. Shramuk
Maxwell E. Shramuk
DBDarren M. Brenner
Darren M. Brenner
INTRODUCTION: Bear down patterns during anorectal manometry are classically evaluated in the left lateral decubitus position. Testing in the seated position may more accurately reflect functional outcomes. METHODS: Overall, 384 adults undergoing anorectal manometry were assessed for dyssynergia in the left lateral decubitus and seated positions. Logistic regression evaluated associations with balloon expulsion testing (BET) outcomes. RESULTS: Normalization of dyssynergic patterns in the seated position occurred in 3.9% (n = 19) resulting in higher odds of successful BET (<1 minute) (OR 30.31; 95% CI 4.09–3,871.75; P < 0.0001). DISCUSSION: Testing in the seated position may more reasonably predict BET success. A seated assessment may enhance diagnostic accuracy in defecation disorders.

25 April 2024 in Cancers
Verified
Journal Article
Open access
PDF file
ZWZhishuo Wei
Zhishuo Wei
PSPriyanka Srinivasan
Priyanka Srinivasan
RPRitam Harin Patel
Ritam Harin Patel
GBGreg Bednarz
Greg Bednarz
JFJohn C. Flickinger
John C. Flickinger
LLL. Dade Lunsford
L. Dade Lunsford
Background: The role of stereotactic radiosurgery (SRS) for patients with brain metastases from hepatopancreaticobiliary (HPB) cancers has yet to be established. The authors present a single-institution experience of patients with HPB cancers who underwent SRS when their cancer spread to the brain. Methods: We surveyed our Gamma Knife SRS data base of 18,000 patients for the years 1987–2022. In total, 19 metastatic HPB cancer patients (13 male) with 76 brain metastases were identified. The median age at SRS was 61 years (range: 48–83). The primary cancer sites were hepatocellular carcinoma (HCC, 11 patients), cholangiocarcinoma (CCC, 2 patients), and pancreatic carcinoma (PCC, 6 patients). The median Karnofsky Performance Score (KPS) was 80 (range: 50–90). Two patients underwent pre-SRS whole-brain fractionated radiation therapy (WBRT) and eight patients underwent pre-SRS surgical resection. All SRS was delivered in single session. The median margin dose was 18 Gy (range: 15–20). The median cumulative tumor volume was 8.1 cc (range: 1.0–44.2). Results: The median patient overall survival (OS) after SRS was 7 months (range 1–79 months). Four patients had documented local tumor progression after SRS at a median time of 8.5 months (range: 2–15) between SRS and progression. Out of 76 treated tumors, 72 tumors exhibited local control. The local tumor control rate per patient was 78.9%. The local tumor control per tumor was 94.7%. Four patients developed new brain metastases at a median of 6.5 months (range: 2–17) after SRS. No patient experienced adverse radiation effects (AREs). At the last follow-up, 18 patients had died, all from systemic disease progression. Conclusions: Metastatic spread to the brain from HPB cancers occurs late in the course of the primary disease. In this study, all deceased patients ultimately died from primary disease progression. SRS is a non-invasive strategy that maximally preserves quality of life, and our results reported favorable outcomes compared to the existing literature. SRS should be considered as one of the primary management strategies for patients with brain metastatic spread from HPB cancer.